ETR:SBS Stratec (SBS) Stock Price, News & Analysis €31.35 +0.80 (+2.62%) As of 10/3/2025 Add Compare Share Share Stock Analysis Stock AnalysisChartHeadlinesBuy This Stock About Stratec Stock (ETR:SBS) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Stratec alerts:Sign Up Key Stats Today's Range€30.00▼€31.3550-Day Range€25.10▼€30.6552-Week Range€36.00▼€49.65Volume7,029 shsAverage Volume6,253 shsMarket Capitalization€376.63 millionP/E Ratio37.62Dividend Yield1.75%Price TargetN/AConsensus RatingN/A Company Overview Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally. It designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers; and offers complex consumables for diagnostics and medical applications. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018. Stratec SE was founded in 1979 and is headquartered in Birkenfeld, Germany. Read More Receive SBS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Stratec and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. SBS Stock News HeadlinesStratec (ETR:SBS) May Have Issues Allocating Its CapitalSeptember 19, 2025 | finance.yahoo.comStratec SE (ETR:SBS) Just Reported Earnings, And Analysts Cut Their Target PriceAugust 23, 2025 | finance.yahoo.comTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. If you do…October 4 at 2:00 AM | Brownstone Research (Ad)Stratec SE (XTER:SBS) (H1 2025) Earnings Call Highlights: Navigating Growth and ChallengesAugust 20, 2025 | gurufocus.comOwning 42% shares,institutional owners seem interested in Stratec SE (ETR:SBS),July 30, 2025 | finance.yahoo.comStratec SE's (ETR:SBS) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?July 8, 2025 | finance.yahoo.comStratec (ETR:SBS) shareholders have endured a 73% loss from investing in the stock three years agoJune 22, 2025 | finance.yahoo.comStratec Full Year 2024 Earnings: EPS Beats ExpectationsMay 21, 2025 | finance.yahoo.comSee More Headlines SBS Stock Analysis - Frequently Asked Questions How have SBS shares performed this year? Stratec's stock was trading at €29.80 at the beginning of 2025. Since then, SBS stock has increased by 5.2% and is now trading at €31.35. What other stocks do shareholders of Stratec own? Based on aggregate information from My MarketBeat watchlists, some other companies that Stratec investors own include Great Portland Estates (GPOR), Gogo (GOGO), Depomed (DEPO), Cenovus Energy (CVE), China Hydroelectric Corp Foreign (CHC), Bio-Rad Laboratories (BIO) and Berkshire Hills Bancorp (BHLB). Industry, Sector and Symbol Stock ExchangeETR SectorMedical Industry Medical Devices Sub-IndustryUtilities Current SymbolETR:SBS CIKN/A Webwww.stratec.com Phone+49-7082-79160FaxN/AEmployees1,464Year FoundedN/AProfitability EPS (Trailing Twelve Months)€0.83 Trailing P/E Ratio37.62 Forward P/E Ratio8.71 P/E Growth10.43Net Income€9.89 million Net Margins4.00% Pretax MarginN/A Return on Equity4.36% Return on Assets4.09% Debt Debt-to-Equity Ratio66.97 Current Ratio2.52 Quick Ratio1.65 Sales & Book Value Annual Sales€247.60 million Price / Sales1.52 Cash Flow€1.31 per share Price / Cash Flow23.85 Book Value€18.74 per share Price / Book1.67Miscellaneous Outstanding Shares12,013,727Free FloatN/AMarket Cap€376.63 million OptionableNot Optionable Beta0.16 Beginner's Guide To Retirement StocksEnter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report This page (ETR:SBS) was last updated on 10/4/2025 by MarketBeat.com Staff From Our PartnersNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | SponsoredURGENT: The Market's 3 Red Flags Are FlashingThe warning signs that preceded the 2008 crash are reappearing: an irrational NASDAQ bubble, a record-high gol...StockEarnings | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredGold to $27,533?This week, U.S. gold reserves hit an unprecedented $1 TRILLION in value... And it's sparking urgent chatter...Stansberry Research | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | SponsoredThe Fed Just Got Kneecapped — Here’s What Happens NextDonald Trump has done it again! This time, with the signing of the highly controversial new law S.1582 — he...Banyan Hill Publishing | SponsoredMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Stratec SE Please log in to your account or sign up in order to add this asset to your watchlist. Share Stratec With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
